FRM
THC icon

Fore Research & Management’s Tenet Healthcare THC Stock Holding History

Fore Research & Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$386K Buy
+20,000
New +$349K 0.17% 33

Other funds holding THC

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fore Research & Management's THC Position: Q2 2017 in Review

Fore Research & Management opened a new position in Tenet Healthcare (THC) in Q2 2017: 20,000 shares worth $386K. The stake represents 0.17% of the portfolio and ranks #33 among its holdings.

246 funds tracked by Wall St. Rank hold THC as of Q2 2017.

  • Fore Research & Management held 20,000 shares of Tenet Healthcare worth $386K as of Q2 2017.
  • Tenet Healthcare was a new Fore Research & Management position in Q2 2017.
  • Tenet Healthcare made up 0.17% of Fore Research & Management's portfolio in Q2 2017, its #33 holding.
  • 246 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2017.

Based on Fore Research & Management's 13F filing for Q2 2017, filed 14 Aug 2017.